Literature DB >> 33011369

Plumula Nelumbinis: A review of traditional uses, phytochemistry, pharmacology, pharmacokinetics and safety.

Sixuan Chen1, Xuping Li1, Junxuan Wu1, Jingyan Li1, Mingzhu Xiao1, Ying Yang1, Zhongqiu Liu1, Yuanyuan Cheng2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Plumula Nelumbinis, the green embryo of the mature seeds of Nelumbo nucifera Gaertn, has a medical history of over 400 years. It is widely used for clearing the heart and heat, calming the mind, and promoting astringent essence and hemostasis in traditional Chinese medicine. Moreover, it usually dual use as food and medicine. This review aimed to evaluate the therapeutic potential of Plumula Nelumbinis by summarizing its botany, traditional uses, phytochemistry, pharmacology, pharmacokinetics and safety.
METHODS: This review summarized published studies on Plumula Nelumbinis in the Chinese Pharmacopoeia and literature databases including PubMed, Web of Science, Baidu Scholar, Wiley and China Knowledge Resource Integrated Database (CNKI), and limits the different research articles in botany, traditional uses, phytochemistry, pharmacology, pharmacokinetics and safety about Plumula Nelumbinis.
RESULTS: Plumula Nelumbinis is used to treat hypertension, arrhythmia, severe aplastic anemia, insomnia, encephalopathy and gynecological disease in traditional Chinese medicine and clinical studies. More than 130 chemicals have been isolated and identified from Plumula Nelumbinis, including alkaloids, flavonoids, polysaccharides and volatile oil. In addition, pharmacological effects, such as protective effects against cardiovascular diseases, neurological diseases, lung and kidney injury, anti-inflammatory and anticancer activities, were also evaluated by in vitro and in vivo studies. Moreover, the potential signaling pathways regulated by Plumula Nelumbinis in cardiovascular and neurological diseases and perspectives on Plumula Nelumbinis research were discussed.
CONCLUSION: Plumula Nelumbinis, a commonly used Chinese medicine, has a variety of traditional and modern therapeutic uses. Some traditional uses, especially the treatment of cardiovascular and neurological diseases, have been verified by pharmacological investigation. However, the pharmacological molecular mechanisms, pharmacokinetics and toxicology of Plumula Nelumbinis are still incomplete. In the future, a series of systematic studies on active compounds identification, pharmacological mechanism clarification, quality and safety evaluation are necessary.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardioprotective effects; Flavonoids; Isoquinoline alkaloids; Neuroprotective effect; Pharmacokinetics; Plumula nelumbinis

Mesh:

Substances:

Year:  2020        PMID: 33011369     DOI: 10.1016/j.jep.2020.113429

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Liensinine Inhibits Cell Growth and Blocks Autophagic Flux in Nonsmall-Cell Lung Cancer.

Authors:  Minghui Chang; Shanshan Ding; Xiaohan Dong; Xiaoling Shang; Yang Li; Li Xie; Xingguo Song; Xianrang Song
Journal:  J Oncol       Date:  2022-07-01       Impact factor: 4.501

Review 2.  Lotus (Nelumbo nucifera Gaertn.) and Its Bioactive Phytocompounds: A Tribute to Cancer Prevention and Intervention.

Authors:  Anupam Bishayee; Palak A Patel; Priya Sharma; Shivani Thoutireddy; Niranjan Das
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.575

Review 3.  Natural Ingredients from Medicine Food Homology as Chemopreventive Reagents against Type 2 Diabetes Mellitus by Modulating Gut Microbiota Homoeostasis.

Authors:  Xiaoyan Xia; Jiao Xiao
Journal:  Molecules       Date:  2021-11-17       Impact factor: 4.411

Review 4.  Higenamine in Plants as a Source of Unintentional Doping.

Authors:  Vanya Rangelov Kozhuharov; Kalin Ivanov; Stanislava Ivanova
Journal:  Plants (Basel)       Date:  2022-01-27

5.  MYPT1 reduction is a pathogenic factor of erectile dysfunction.

Authors:  Wei Zhao; Jie Sun; Liang-Yu Yao; Dong Hang; Ye-Qiong Li; Cai-Ping Chen; Yu-Wei Zhou; Xin Chen; Tao Tao; Li-Sha Wei; Yan-Yan Zheng; Xie Ge; Chao-Jun Li; Zhong-Cheng Xin; Yang Pan; Xin-Zhu Wang; Wei-Qi He; Xue-Na Zhang; Bing Yao; Min-Sheng Zhu
Journal:  Commun Biol       Date:  2022-07-25

6.  Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis.

Authors:  Xinghua Xiao; Fangmei Luo; Minyi Fu; Yueping Jiang; Shao Liu; Bin Liu
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.